Skip to Main Content

Paper Details

A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
PLoS One
131
2014
293T cells, 3' splice site, AML, CAG, CHCHD7, CTNNB1, Cancer, Cancer Gene Census, HeLa cells, PICALM, RNA, S34F, U2AF1, U2AF1 S34F, U2AF1 mutations, U2AF35, UAG 3' splice site sequences, acute myeloid leukemias, cancer, cancer cell types, cancer transcriptome, cancers, lung adenocarcinoma, lung adenocarcinomas
Author NameAffiliation
Angela Brooks-WilsonBroad Institute of Harvard and Massachusetts Institute of Technology, Dana-Farber Cancer Institute
Marcin ImielinskiBroad Institute of Harvard and Massachusetts Institute of Technology, Dana-Farber Cancer Institute
Gordon SaksenaBroad Institute of Harvard and Massachusetts Institute of Technology
Gordon SaksenaBroad Institute of Harvard and Massachusetts Institute of Technology
Chandra Sekhar PedamalluBroad Institute of Harvard and Massachusetts Institute of Technology, Dana-Farber Cancer Institute
Chandra Sekhar PedamalluBroad Institute of Harvard and Massachusetts Institute of Technology, Dana-Farber Cancer Institute
Andrey SivachenkoBroad Institute of Harvard and Massachusetts Institute of Technology
Andrey SivachenkoBroad Institute of Harvard and Massachusetts Institute of Technology
Mara RosenbergBroad Institute of Harvard and Massachusetts Institute of Technology
Mara RosenbergBroad Institute of Harvard and Massachusetts Institute of Technology
Michael S LawrenceBroad Institute of Harvard and Massachusetts Institute of Technology
David S DeLucaBroad Institute of Harvard and Massachusetts Institute of Technology
David S DeLucaBroad Institute of Harvard and Massachusetts Institute of Technology
Gad GetzBroad Institute of Harvard and Massachusetts Institute of Technology
Gad GetzBroad Institute of Harvard and Massachusetts Institute of Technology
Matthew MeyersonBroad Institute of Harvard and Massachusetts Institute of Technology, Dana-Farber Cancer Institute, Harvard Medical School
Matthew MeyersonBroad Institute of Harvard and Massachusetts Institute of Technology, Dana-Farber Cancer Institute, Harvard Medical School
  • 1 - 17

Datasets